PMC4521682_01
PMC4521682_02
Rivaroxaban concentrations (microg/mL) measured after second 150 mg rivaroxaban dose, followed within ten minutes by 50 g activated charcoal, and three hours after first rivaroxaban dose of 15 mg. Expected rivaroxaban concentrations are derived from Mueck et al (Table 3 and Fig. 3).
ccrep-8-2015-057f1.jpg
PMC4521682_02_ccrep-8-2015-057f1.jpg
f1-ccrep-8-2015-057
Thromboplastin Time (APTT) were monitored (Figs. 1 and 2). The overdose was uncomplicated, and 15 mg twice daily rivaroxaban was restarted on day 2.
Prothrombin Time (PT), APTT, and INR before rivaroxaban, after the second 150 mg rivaroxaban dose followed within ten minutes by 50 g activated charcoal, and three hours after the first rivaroxaban dose of 15 mg.
ccrep-8-2015-057f2.jpg
PMC4521682_02_ccrep-8-2015-057f2.jpg
f2-ccrep-8-2015-057
Thromboplastin Time (APTT) were monitored (Figs. 1 and 2). The overdose was uncomplicated, and 15 mg twice daily rivaroxaban was restarted on day 2.